Development of Albumin Nanocarriers for Enhanced Curcumin Delivery and In Vitro Anticancer Activity in Colon Cancer Cells.

Aftab Ahmad, Darshana Bagwe, Shagufta Khan, Chetna Dhone, Shilpa Padhare, Anwar A Alghamdi, Shah Alam Khan

Abstract read

In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aftab AhmadHealth Information Technology Department, The Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-8268-3412

Darshana BagweDepartment of Pharmaceutics, Institute of Pharmaceutical Education and Research, Wardha Borgaon (Meghe), Wardha 442 001, Maharashtra, India.

Shagufta KhanDepartment of Pharmaceutics, Institute of Pharmaceutical Education and Research, Wardha Borgaon (Meghe), Wardha 442 001, Maharashtra, India.

Chetna DhoneDepartment of Pharmaceutics, Institute of Pharmaceutical Education and Research, Wardha Borgaon (Meghe), Wardha 442 001, Maharashtra, India.

Shilpa PadhareDepartment of Pharmaceutics, Institute of Pharmaceutical Education and Research, Wardha Borgaon (Meghe), Wardha 442 001, Maharashtra, India.

Anwar A AlghamdiHealth Information Technology Department, The Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-8474-2543

Shah Alam KhanDepartment of Pharmaceutical Chemistry, College of Pharmacy, National University of Science and Technology, Bousher, Muscat PC 130, Oman.ORCID 0000-0002-0729-3403

Funding

The Ministry of Education and King Abdulaziz University, DSR, Jeddah, Saudi Arabia. IFPIP:1100-156-1443

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

albumin nanocarriersanticancer nanomedicinebovine serum albuminColo-205 cellscolon cancercontrolled releasecurcuminpH-dependent drug deliveryprotein-based nanoparticles

Identifiers

PMID42356490

DOI10.3390/ph19060872

PMCPMC13305700

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.